SLC35A1 and aspartylglucosaminuria: To test the suitability of the SLC35A1 knockout cells for a potency assay, we used an AAV9 vector (AAV9/AGA) that carries the optimized human AGA gene coding for aspartylglucosaminidase (AGA) that is deficient in aspartylglucosaminuria (AGU).